Klebsiella Testing Market Report Spreads In 97 Pages with 131 Tables and Figures
Klebsiella Testing Market 2023 : Klebsiella is a genus of gram-negative, rod-shaped bacteria. Klebsiella normally lives inside human intestine but it does not cause any disease in intestine. Klebsiella cause a range of illness to the human body including, pneumonia, wound infection, surgical site infection, bloodstream infection, urinary tract infection and meningitis.
Report Overview
Due to the COVID-19 pandemic and Russia-Ukraine War Influence, the global market for Klebsiella Testing estimated at US$ million in the year 2022, is projected to reach a revised size of US$ million by 2028, growing at a CAGR of % during the forecast period 2022-2028.
This bacteria is an opportunistic organism and can infect people with weakened immune system. Increasing prevalence of conditions that are responsible for weakening of immune system are expected to fuel the growth of the klebsiella testing market.
Top Key Players:
- Charles River Laboratories
- HiMedia Laboratories
- Biomed Diagnostics
- Bio SB
- Miacom Diagnostics
- Abcam
- EastCoast Bio
- Medical Diagnostic
Klebsiella Testing Market By Applications
- Hospitals
- Diagnostic Laboratories
- Diagnostic Imaging Centers
- Other
Klebsiella Testing Market By Types
- Laboratory Test
- Imaging Test
- Other
Get a Sample PDF of report –https://www.360researchreports.com/enquiry/request-sample/21728751
About The Author
